In this study, we demonstrated the role of SAPK/JNK and MEK/ERK1/2 signaling pathways in mediating the effect of curcumin and bicalutamide on controlling growth of androgen-independent prostate cancer cells. The gene discussed is MAPK9; the disease is prostate cancer.